Efficacy of intraperitoneal amino acid (IPAA) dialysate in an Asian vegetarian patient with chronic hypoalbuminaemia

EDTNA ERCA J. 1998 Apr-Jun;24(2):28-32.

Abstract

Protein-calorie malnutrition is commonly found in chronic CAPD patients and is a matter of concern since low serum albumin levels correlate with an increased risk of morbidity and mortality. Recognition of this link has therefore led to a growing interest in the efficacy of IPAA therapy as a possible treatment option. The present case study took place within a larger, ongoing clinical trial and outlines our experience of administering one exchange of 1.1% IPAA (Nutrineal, Baxter Healthcare Ltd) per day over 18 weeks to a patient identified as being protein malnourished.

Publication types

  • Case Reports
  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Amino Acids / therapeutic use*
  • Blood Urea Nitrogen
  • Cross-Over Studies
  • Dialysis Solutions / therapeutic use*
  • Diet, Vegetarian / adverse effects*
  • Female
  • Humans
  • Infusions, Parenteral
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy
  • Middle Aged
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Protein-Energy Malnutrition / drug therapy*
  • Protein-Energy Malnutrition / etiology*
  • Protein-Energy Malnutrition / metabolism
  • Serum Albumin / deficiency*

Substances

  • Amino Acids
  • Dialysis Solutions
  • Serum Albumin